Frequently asked question

Do you support early-stage companies as well as established manufacturers?

XGene's service scope is relevant to both development-stage sponsors and established pharmaceutical or life-sciences organizations. Early-stage companies may need help building an IND-ready CMC roadmap, identifying Module 3 gaps, defining control-strategy evidence, preparing for…

Browse FAQs

Answer

XGene’s service scope is relevant to both development-stage sponsors and established pharmaceutical or life-sciences organizations. Early-stage companies may need help building an IND-ready CMC roadmap, identifying Module 3 gaps, defining control-strategy evidence, preparing for CDMO transfer, or establishing scalable quality practices. Established manufacturers may need targeted remediation, data-integrity assessment, inspection-response support, batch-record review, supplier oversight, or quality-system improvement. The exact engagement should be defined around product stage, regulatory pathway, internal capability, risk, and the decision the client needs to make.

When the answer needs context

Connect the question to the evidence and the decision.

Use XGene intelligence or bring the specific technical situation into a focused conversation.

Discuss a Project